Abstract
Presented at the Midyear Clinical Meeting.
While most patients met individual KDIGO finerenone initiation criteria, fewer than one-third met all guideline recommended parameters. Guideline directed K+ monitoring following initiation was underperformed, highlighting a need for improved follow up Procedures.
Document Type
Poster
Publication Date
2025
Recommended Citation
Beckett, Robert D., "Use of finerenone for chronic kidney disease in type 2 diabetes: a cross-sectional study at a large health system" (2025). Parkview Pharmacy Department. 105.
https://researchrepository.parkviewhealth.org/pharma/105